Development
The first gene therapy for genetic hearing loss is approved in 61 days
Claim
The FDA approved the first gene therapy for genetic hearing loss just 61 days after filing under its priority voucher programme.
Reported metric: 61 days
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to April 26, 2026 (theinnermostloop.substack.com)
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.